<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">J Enzyme Inhib Med Chem</span><span class="iso-abbrev" title="iso-abbrev">J Enzyme Inhib Med Chem</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Journal of Enzyme Inhibition and Medicinal Chemistry</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">1475-6366</span><span class="issn-epub" tagx="issn" title="issn-epub">1475-6374</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Taylor &amp;amp; Francis</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7850424">7850424</a></span><span class="pmid" title="pmid"> pmid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/33491508">33491508</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1080/14756366.2021.1873977">10.1080/14756366.2021.1873977</a></span><span class="publisher-id" title="publisher-id">1873977</span><div class="unknown" title="article-version" tag="article-version">
Version of Record</div> <div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Research Article</span>: <span class="subject" title="subject">Research Paper</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title"><i>Scutellaria baicalensis</i> extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease <i>inÂ vitro</i></div> <div class="alt-title" title="alt-title">
H. Liu et al.</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Hongbo</span></span><a href="#AF0001">a</a><a href="#FN0001" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ye</span><span class="given-names" tagx="given-names" title="given-names">Fei</span></span><a href="#AF0002">b</a><a href="#FN0001" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">Qi</span></span><a href="#AF0001">a</a><a href="#FN0001" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liang</span><span class="given-names" tagx="given-names" title="given-names">Hao</span></span><a href="#AF0001">a</a><a href="#FN0001" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Chunmei</span></span><a href="#AF0003">c</a><a href="#FN0001" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Siyang</span></span><a href="#AF0003">c</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">Roujian</span></span><a href="#AF0002">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">Baoying</span></span><a href="#AF0002">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tan</span><span class="given-names" tagx="given-names" title="given-names">Wenjie</span></span><a href="#AF0002">b</a><a href="#AN0002" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lai</span><span class="given-names" tagx="given-names" title="given-names">Luhua</span></span><a href="#AF0001">a</a><a href="#AF0003">c</a><a href="#AN0001" /></span><span class="citation_author_institution" id="AF0001">[a], <span class="institution" title="institution">BNLMS, Peking-Tsinghua Center for Life Sciences at College of Chemistry and Molecular Engineering, Peking University</span><span class="city" tagx="city" title="city">Beijing</span><span class="country" tagx="country" title="country">China</span></span><span class="citation_author_institution" id="AF0002">[b], <span class="institution" title="institution">NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, China CDC</span><span class="city" tagx="city" title="city">Beijing</span><span class="country" tagx="country" title="country">China</span></span><span class="citation_author_institution" id="AF0003">[c], <span class="institution" title="institution">Center for Quantitative Biology, Academy for Advanced Interdisciplinary Studies, Peking University</span><span class="city" tagx="city" title="city">Beijing</span><span class="country" tagx="country" title="country">China</span></span></div> <div class="author-notes" title="author-notes"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">*</span><p>These authors contributed equally to this work.</p> </div> <div class="fn-type-" title=""> <p>Supplemental data for this article can be accessed <a href="https://doi.org/10.1080/14756366.2021.1873977"><u>here</u></a>.</p> </div> <div class="corresp" title="corresp">
CONTACT Luhua Lai <span class="email" tagx="email" title="email">lhlai@pku.edu.cn</span><span class="institution" title="institution">College of Chemistry and Molecular Engineering, Peking University</span>, <span class="city" tagx="city" title="city">Beijing</span><span class="postal-code" tagx="postal-code" title="postal-code">100871</span>, <span class="country" tagx="country" title="country">China</span></div> <div class="corresp" title="corresp">
Wenjie Tan <span class="email" tagx="email" title="email">tanwj28@163.com</span><span class="institution" title="institution">NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention</span>, <span class="addr-line" title="addr-line">China CDC</span>, <span class="city" tagx="city" title="city">Beijing</span><span class="postal-code" tagx="postal-code" title="postal-code">102206</span>, <span class="country" tagx="country" title="country">China</span></div> </div><span class="pub-date-" title="pub-date-">: <span>2021-1-1</span></span><span class="pub-date-" title="pub-date-">: <span>2021</span></span><span class="volume" tagx="volume" title="volume">36</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">497</span><span class="lpage" tagx="lpage" title="lpage">503</span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">The Author(s)</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2021</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<a href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</a>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</span></span></div><a class="self-uri" href="IENZ_36_1873977.pdf" title="self-uri">IENZ_36_1873977.pdf</a><div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Abstract</div> <p>COVID-19 has become a global pandemic and there is an urgent call for developing drugs against the virus (SARS-CoV-2). The 3C-like protease (3CL<sup>pro</sup>) of SARS-CoV-2 is a preferred target for broad spectrum anti-coronavirus drug discovery. We studied the anti-SARS-CoV-2 activity of <i>S. baicalensis</i> and its ingredients. We found that the ethanol extract of <i>S. baicalensis</i> and its major component, baicalein, inhibit SARS-CoV-2 3CL<sup>pro</sup> activity <i>inÂ vitro</i> with IC<sub>50</sub>â€™s of 8.52Â Âµg/ml and 0.39Â ÂµM, respectively. Both of them inhibit the replication of SARS-CoV-2 in Vero cells with EC<sub>50</sub>â€™s of 0.74Â Âµg/ml and 2.9Â ÂµM, respectively. While baicalein is mainly active at the viral post-entry stage, the ethanol extract also inhibits viral entry. We further identified four baicalein analogues from other herbs that inhibit SARS-CoV-2 3CL<sup>pro</sup> activity at ÂµM concentration. All the active compounds and the <i>S. baicalensis</i> extract also inhibit the SARS-CoV 3CL<sup>pro</sup>, demonstrating their potential as broad-spectrum anti-coronavirus drugs.</p> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
COVID-19</div> <div class="kwd" title="kwd">
SARS-CoV-2</div> <div class="kwd" title="kwd">
3C-like protease</div> <div class="kwd" title="kwd"><i>Scutellaria baicalensis</i></div> <div class="kwd" title="kwd">
baicalein</div> </div> <div class="counts" title="counts"><span class="fig-count" title="fig-count">fig-count: </span><span class="table-count" title="table-count">table-count: </span><span class="page-count" title="page-count">page-count: </span><span class="word-count" title="word-count">word-count: </span></div> </div> </div> <div class="body" title="body"> <div class="intro" title="intro"><span class="label" tagx="label" title="label">1.</span><div class="title" tagx="title" title="title">
Introduction</div> <p>Coronaviruses (CoVs) are single stranded positive-sense RNA viruses that cause severe infections in respiratory, hepatic, and various organs in humans and many other animals<a href="#CIT0001"><sup>1</sup></a><sup>,</sup><a href="#CIT0002"><sup>2</sup></a>. Within the 20Â years of the twenty-first century, there are already three outbreaks of CoV-causing global epidemics, including SARS, MERS, and COVID-19. The newly emerged CoV infectious disease (COVID-19) has become a worldwide pandemic that needs to be controlled. There is an urgent call for drug and vaccine research and development against COVID-19.</p> <p>COVID-19 was confirmed to be caused by a new coronavirus (SARS-CoV-2), whose genome was sequenced in early January 2020<a href="#CIT0003"><sup>3</sup></a><sup>,</sup><a href="#CIT0004"><sup>4</sup></a>. The genomic sequence of SARS-CoV-2 is highly similar to that of SARS-CoV with about 79.6% sequence identity<a href="#CIT0005"><sup>5</sup></a> and remains stable up to now<a href="#CIT0006"><sup>6</sup></a>. However, the sequence identities vary significantly for different viral proteins<a href="#CIT0005"><sup>5</sup></a>. For instance, the spike proteins (S-protein) in CoVs are diverse in sequences and even in the host receptors that bind due to the rapid mutations and recombination<a href="#CIT0007"><sup>7</sup></a>. Although it has been confirmed that both SARS-CoV and SARS-CoV-2 use ACE2 as receptor and occupy the same binding site, their binding affinities to ACE2 vary due to subtle interface sequence variations<a href="#CIT0008"><sup>8</sup></a>. On the contrary, the 3C-like proteases (3CL<sup>pro</sup>) in CoVs are highly conserved. The 3CL<sup>pro</sup> in SARS-CoV and SARS-CoV-2 share a sequence identity of 96.1%, making it an ideal target for broad spectrum anti-CoV therapy. Although many inhibitors have been reported for SARS-CoV and MERS-CoV 3CL<sup>pro</sup><a href="#CIT0009"><sup>9â€"12</sup></a>, unfortunately none of them has entered clinical trial. Inspired by the previous studies, several covalent inhibitors were rationally designed and experimentally shown to inhibit the 3CL<sup>pro</sup> activity and viral replication of SARS-CoV-2, with some of the complex crystal structures solved<a href="#CIT0013"><sup>13â€"15</sup></a>. In addition, a number of clinically used HIV and HCV protease inhibitors have been proposed as possible cure for COVID-19<a href="#CIT0016"><sup>16</sup></a> and some of them are now processed to clinically trials<a href="#CIT0017"><sup>17</sup></a>. Most of the reported SARS-CoV-2 3CL<sup>pro</sup> inhibitors covalently target the active site cysteine. Highly potent SARS-CoV-2 3CL<sup>pro</sup> inhibitors with diverse chemical structures and mode of action need to explored.</p> <p>Traditional Chinese medicine (TCM) herbs and formulae have long been used in treating viral diseases. Some of them have been clinically tested to treat COVID-19<a href="#CIT0018"><sup>18</sup></a>. Scutellariae radix (Huangqin in Chinese), the root of <i>Scutellaria baicalensis</i> Georgi, has been reported for widely used in TCM for heat clearing, fire purging, detoxification, and haemostasis. Huangqin is officially recorded in Chinese Pharmacopoeia (2015 Edition)<a href="#CIT0019"><sup>19</sup></a> and European Pharmacopoeia (10th Edition)<a href="#CIT0020"><sup>20</sup></a>. Its anti-tumour, antiviral, anti-microbial, and anti-inflammatory activities have been reported<a href="#CIT0021"><sup>21</sup></a>. Remarkably, the extracts of <i>S. baicalensis</i> have exhibited broad spectrum anti-viral activities, including ZIKA<a href="#CIT0022"><sup>22</sup></a>, H1N1<a href="#CIT0023"><sup>23</sup></a>, HIV<a href="#CIT0024"><sup>24</sup></a>, and DENV<a href="#CIT0025"><sup>25</sup></a>. In addition, a multicentre, retrospective analysis demonstrated that <i>S. baicalensis</i> exhibits more potent antiviral effects and higher clinical efficacy than ribavirin for the treatment of hand, foot, and mouth disease<a href="#CIT0026"><sup>26</sup></a>. Several <i>S. baicalensis</i> derived mixtures or pure compounds have been approved as antiviral drugs, such as Baicalein capsule (to treat hepatitis) and Huangqin tablet (to treat upper respiratory infection) in China. Most of the <i>S. baicalensis</i> ingredients are flavonoids<a href="#CIT0027"><sup>27</sup></a>. Flavonoids from other plants were also reported to mildly inhibit SARS and MERS-CoV 3CL<sup>pro</sup><a href="#CIT0028"><sup>28</sup></a><sup>,</sup><a href="#CIT0029"><sup>29</sup></a>. Here, we studied the anti-SARS-CoV-2 activity of <i>S. baicalensis</i> and its ingredients. We found that the ethanol extract of <i>S. baicalensis</i> inhibits SARS-CoV-2 3CL<sup>pro</sup> activity and the most active ingredient baicalein exhibits an IC<sub>50</sub> of 0.39Â ÂµM. Both the ethanol extract of <i>S. baicalensis</i> and baicalein effectively inhibit the replication of SARS-CoV-2 in cell assay. The anti-SARS-CoV-2 3CL<sup>pro</sup> activity and antiviral activity were also reported by a recent publication<a href="#CIT0030"><sup>30</sup></a>. We further studied the structure and activity relationship of baicalein analogues and identified four new active compounds from other herbs that inhibit SARS-CoV-2 3CL<sup>pro</sup> activity at ÂµM concentration.</p> </div> <div class="materials" title="materials"><span class="label" tagx="label" title="label">2.</span><div class="title" tagx="title" title="title">
Materials and methods</div> <p><i>S. baicalensis</i> were purchased from Tong Ren Tang Technologies Co. Ltd. (Beijing, China). Baicalein and compounds not listed below were from J&amp;amp;K Scientific (Beijing, China). 5,6-Dihydroxyflavone was purchased from Alfa Aesar (Haverhill, MA). 6,7-Dihydroxyflavone was synthesised by Shanghai Yuanye Biotechnology Co., Ltd. (Shanghai, China). Myricetin, quercetagetin, and herbacetin were purchased from MCE (Shanghai, China). Dihydromyricetin and myricetin were purchased from Targetmol (Boston, MA). </p> <div class="constructionofplasmidsars-cov-2pet3cl-21x,proteinexpression,andpurification" title="sec"><span class="label" tagx="label" title="label">2.1.</span><div class="title" tagx="title" title="title">
Construction of plasmid SARS-CoV-2 pET 3CL-21x, protein expression, and purification</div> <p>The DNA of SARS-CoV-2 3CL<sup>pro</sup> (referred to GenBank, accession number MN908947) was synthesised (Hienzyme Biotech, Changsha, China) and amplified by PCR using primers n3CLP-Nhe (5â€²-CATGGCTAGCGGTTTTAGAAAAATGGCATTCCC-3â€²) and n3CLP-Xho (5â€²-CACTCTCGAGTTGGAAAGTAACACCTGAGC-3â€²). The PCR product was digested with <i>Nhe</i> I/<i>Xho</i> I and cloned into the pET 21a DNA as reported previously<a href="#CIT0031"><sup>31</sup></a>. The resulting SARS-CoV-2 pET 3CL-21x plasmid encodes a 35,064â€‰Da SARS-CoV-2 3CL<sup>pro</sup> with a C-terminal 6xHis-tag. The SARS-CoV-2 pET 3CL-21x plasmid was further transformed to <i>E. coli</i> BL21â€‰<div class="â€‰de3_UNKNOWN">
 for protein expression as reported<a href="#CIT0031"><sup>31</sup></a>. The recombinant protein was purified through a nickel-nitrilotriacetic acid column (GE Healthcare, Chicago, IL) and subsequently loaded on a gel filtration column Sephacryl S-200â€‰HR (GE Healthcare, Chicago, IL) for further purification as previously described<a href="#CIT0032"><sup>32</sup></a>.</div></p> </div> <div class="preparationoftheethanolextractofs.baicalensis" title="sec"><span class="label" tagx="label" title="label">2.2.</span><div class="title" tagx="title" title="title">
Preparation of the ethanol extract of <i>S. baicalensis</i></div> <p>After minced, 5â€‰g <i>S. baicalensis</i> was extracted with 100â€‰ml of 70% ethanol in a 300â€‰ml flask after sonication for 1â€‰h at 25â€‰Â°C. The solvent was filtrated and completely removed under reduced pressure at room temperature. The residue was freeze-dried overnight. The dried herbal residue was then dissolved completely to obtain a 100â€‰mg/ml stock solution in DMSO which was stored at âˆ’20â€‰Â°C before use.</p> </div> <div class="enzymeinhibitionassay" title="sec"><span class="label" tagx="label" title="label">2.3.</span><div class="title" tagx="title" title="title">
Enzyme inhibition assay</div> <p>A colorimetric substrate Thr-Ser-Ala-Val-Leu-Gln-pNA (GL Biochemistry Ltd., Shanghai, China) and assay buffer (40â€‰mM PBS, 100â€‰mM NaCl, 1â€‰mM EDTA, 0.1% Triton 100, pH 7.3) was used for the inhibition assay. Stock solutions of the inhibitors were prepared with 100% DMSO. The 100Â Âµl reaction systems in assay buffer contain 0.5Â ÂµM protease and 5% DMSO or inhibitor to the final concentration. First, SARS-CoV-2 3CL<sup>pro</sup> was diluted with assay buffer to the desired concentration. Five microlitres DMSO or inhibitor at various concentrations was pre-incubated with 85Â Âµl diluted SARS-CoV-2 3CL<sup>pro</sup> for 30â€‰min at room temperature. Then 10Â Âµl 2â€‰mM substrate Thr-Ser-Ala-Val-Leu-Gln-pNA (dissolved in water) was added into the above system to the final concentration of 200Â ÂµM to initiate the reaction. Increase in absorbance at 390â€‰nm was recorded for 20â€‰min at interval of 30â€‰s with a kinetics mode program using a plate reader (Synergy, Biotek, Winooski, VT). The percent of inhibition was calculated by <i>V</i><sub>i</sub>/<i>V</i><sub>0</sub>, where <i>V</i><sub>0</sub> and <i>V</i><sub>i</sub> represent the mean reaction rate of the enzyme incubated with DMSO or compounds. IC<sub>50</sub> was fitted with Hill1 function.</p> </div> <div class="moleculardocking" title="sec"><span class="label" tagx="label" title="label">2.4.</span><div class="title" tagx="title" title="title">
Molecular docking</div> <p>The structure of SARS-CoV-2 3CL<sup>pro</sup> (PDB ID 6LU7)<a href="#CIT0013"><sup>13</sup></a> and <i>S. baicalensis</i> components were prepared using Protein Preparation Wizard and LigPrep module, respectively. Then, the binding site was defined as a 20â€‰Ã—â€‰20â€‰Ã—â€‰20Â Ã…<sup>3</sup> cubic box centred to the centroid of C145. After that, molecular docking was performed using Glide. Extra precision (XP) and flexible ligand sampling were adopted. Post-docking minimisation was performed to further refine the docking results. All the above-mentioned modules were implemented in SchrÃ¶dinger version 2015-4 (SchrÃ¶dinger Software Suite, L.L.C., New York, NY, 2015).</p> </div> <div class="cellcultureandvirus" title="sec"><span class="label" tagx="label" title="label">2.5.</span><div class="title" tagx="title" title="title">
Cell culture and virus</div> <p>Vero cell line (ATCC, CCL-81) was cultured at 37â€‰Â°C in Dulbeccoâ€™s modified Eagleâ€™s medium (DMEM, Gibco, Grand Island, NY) supplemented with 10% foetal bovine serum (FBS, Gibco, Grand Island, NY) in the atmosphere with 5% CO<sub>2</sub>. Cells were digested with 0.25% trypsin and uniformly seeded in 96-well plates with a density of 2â€‰Ã—â€‰10<sup>4</sup> cells/well prior infection or drug feeding. The virus (C-Tan-nCoV Wuhan strain 01) used is a SARS-CoV-2 clinically isolated virus strain. These viruses were propagated in Vero cells.</p> </div> <div class="antiviralactivityassay" title="sec"><span class="label" tagx="label" title="label">2.6.</span><div class="title" tagx="title" title="title">
Antiviral activity assay</div> <p>The cytotoxicity of <i>S. baicalensis</i> extract and baicalein on Vero cells were determined by CCK8 assays (DOJINDO, Kumamoto, Japan). We then evaluated the antiviral efficiency of <i>S. baicalensis</i> extract and baicalein against SARS-CoV-2 (C-Tan-nCoV Wuhan strain 01) virus <i>inÂ vitro</i>. Cells were seeded into 96-well plates at a density of 2â€‰Ã—â€‰10<sup>4</sup> cells/well and then grown for 24â€‰h. For the full-time inhibition test, cells were pre-treated with indicated concentrations of <i>S. baicalensis</i> extract or baicalein for 1â€‰h, and the virus (MOI of 0.01, 200Â PFU/well) was subsequently added to allow infection for 2â€‰h at 37â€‰Â°C. Virus input was washed with DMEM and then the cells were treated with medium containing the drugs at various concentrations for 48â€‰h. For the entry inhibition test, after viral infection for 2â€‰h, both the virus input and the drugs were washed out with DMEM and the cells were treated with fresh medium without drugs for 48â€‰h. For the post-entry inhibition test, the drugs were added only after 2â€‰h of viral infection and maintained until the end of the experiment. The supernatant was collected and the RNA was extracted and analysed by relative quantification using RT-PCR as in the previous study<a href="#CIT0033"><sup>33</sup></a>.</p> </div> <div class="rnaextractionandrt-qpcr" title="sec"><span class="label" tagx="label" title="label">2.7.</span><div class="title" tagx="title" title="title">
RNA extraction and RT-qPCR</div> <p>Viral RNA was extracted from 100â€‰Î¼l supernatant of infected cells using the automated nucleic acid extraction system (TIANLONG, Hangzhou, China), following the manufacturerâ€™s recommendations. SARS-CoV-2 virus detection was performed using the One Step PrimeScript RT-PCR kit (TaKaRa, Shiga, Japan) on the LightCycler 480 Real-Time PCR system (Roche, Rotkreuz, Switzerland). ORF 1ab was amplified from cDNA and cloned into MS2-nCoV-ORF1ab and used as the plasmid standard after its identity was confirmed by sequencing. A standard curve was generated by determination of copy numbers from serially dilutions (10<sup>3</sup>â€"10<sup>9</sup> copies) of plasmid. The following primers used for quantitative PCR were 1ab-F: 5â€²-AGAAGATTGGTTAGATGATGATAGT-3â€²; 1ab-R: 5â€²-TTCCATCTCTAATTGAGGTTGAACC-3â€²; and probe 5â€²-FAM-TCCTCACTGCCGTCTTGTTG ACCA-BHQ1-3â€². The individual EC<sub>50</sub> values were calculated by the Origin 2018 software.</p> </div> </div> <div class="results" title="results"><span class="label" tagx="label" title="label">3.</span><div class="title" tagx="title" title="title">
Results and discussion</div> <div class="theethanolextractofs.baicalensisstronglyinhibitssars-cov-23clpro" title="sec"><span class="label" tagx="label" title="label">3.1.</span><div class="title" tagx="title" title="title">
The ethanol extract of <i>S. baicalensis</i> strongly inhibits SARS-CoV-2 3CL<sup>pro</sup></div> <p>We first prepared the 70% ethanol extract of <i>S. baicalensis</i> and tested its inhibitory activity against SARS-CoV-2 3CL<sup>pro</sup>. We expressed SARS-CoV-2 3CL<sup>pro</sup> and performed activity assay using a peptide substrate (Thr-Ser-Ala-Val-Leu-Gln-pNA) according to the published procedure of SARS-CoV 3CL<sup>pro</sup> assay<a href="#CIT0010"><sup>10</sup></a><sup>,</sup><a href="#CIT0034"><sup>34</sup></a>. As shown in <a href="#F0001">Figure 1(A)</a>, the crude extract exhibits significant inhibitory effect with an IC<sub>50</sub> of 8.5Â Âµg/ml, suggesting that <i>S. baicalensis</i> contains candidate inhibitory ingredients against SARS-CoV-2 3CL<sup>pro</sup>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 1.</span></a></div>   <p>The <i>inÂ vitro</i> anti-SARS-CoV-2 3CL<sup>pro</sup> activity of <i>S. baicalensis</i> ethanol extract (A) and baicalein (B).</p>   </div> </div> <div class="baicaleinisthemajoractiveingredientins.baicalensisthatinhibitssars-cov-23clpro" title="sec"><span class="label" tagx="label" title="label">3.2.</span><div class="title" tagx="title" title="title">
Baicalein is the major active ingredient in <i>S. baicalensis</i> that inhibits SARS-CoV-2 3CL<sup>pro</sup></div> <p>We then tested the inhibitory activity of four major ingredients from <i>S. baicalensis</i>: baicalein, baicalin, wogonin, and wogonoside <i>inÂ vitro</i>. Baicalein showed the most potent anti-SARS-CoV-2 3CL<sup>pro</sup> activity with an IC<sub>50</sub> of 0.39Â ÂµM (<a href="#F0001">Figure 1(B)</a> and <a href="#t0001">Table 1</a>). Baicalin inhibited SARS-CoV-2 3CL<sup>pro</sup> activity for about 41% at 50â€‰ÂµM with an IC<sub>50</sub> of 83.4Â ÂµM (<a href="https://doi.org/10.1080/14756366.2021.1873977">Figure S1</a>), while wogonin and wogonoside were not active at this concentration. The ratio of baicalein in the crude extract determined by HPLC was 2.07% (<a href="https://doi.org/10.1080/14756366.2021.1873977">Table S2</a>) which is in consistent with previous reports<a href="#CIT0035"><sup>35</sup></a>. To eliminate possible non-specific effect, the inhibitory activity of ethanol extract and all the compounds were measured in the buffer with 0.1% Triton X-100.</p> <div class="table-wrap_UNKNOWN" id="t0001" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 1.</span> <p>The SARS-CoV-2 3CL<sup>pro</sup> inhibition activity of four major flavones derived from <i>S. baicalensis</i>.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th align="left">Compound</th> <th align="center">Chemical structure</th> <th align="center">IC<sub>50</sub> (Î¼M)</th> <th align="center">% Inhibition at 50â€‰Î¼M</th> </tr> </thead> <tbody valign="top"> <tr> <td align="left">Baicalein</td> <td align="left"><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">0.39â€‰Â±â€‰0.12</td> <td align="center">â€"</td> </tr> <tr> <td align="left">Baicalin</td> <td align="left"><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">83.4â€‰Â±â€‰0.9</td> <td align="char" char=".">41.5â€‰Â±â€‰0.6</td> </tr> <tr> <td align="left">Wogonin</td> <td align="left"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center">â€"</td> <td align="char" char=".">6.1â€‰Â±â€‰0.8</td> </tr> <tr> <td align="left">Wogonoside</td> <td align="left"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center">â€"</td> <td align="char" char=".">8.5â€‰Â±â€‰3.3</td> </tr> </tbody> </table> </div> </div> <div class="s.baicalensisextractandbaicaleininhibitthereplicationofsars-cov-2inverocells" title="sec"><span class="label" tagx="label" title="label">3.3.</span><div class="title" tagx="title" title="title"><i>S. baicalensis</i> extract and baicalein inhibit the replication of SARS-CoV-2 in Vero cells</div> <p>We further tested the antiviral activity of <i>S. baicalensis</i> ethanol extract and baicalein against SARS-CoV-2 using RT-qPCR. Vero cells were pre-treated with the extract or baicalein for 1â€‰h, followed by virus infection for 2â€‰h. Virus input was then washed out and the cells were treated with medium containing the extract or baicalein. Viral RNA was extracted from the supernatant of the infected cells and quantified by RT-PCR. The <i>S. baicalensis</i> ethanol extract significantly reduced the growth of the virus with an EC<sub>50</sub> of about 0.74Â Âµg/ml with low cytotoxicity (SI &amp;gt; 675, <a href="#F0002">Figure 2(A,C)</a>). Baicalein inhibits the replication of SARS-CoV2 with an EC<sub>50</sub> of 2.9Â ÂµM and SI &amp;gt; 172 (<a href="#F0002">Figure 2(B,D)</a>).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 2.</span></a></div>   <p>The antiviral activity and cytotoxicity of <i>S. baicalensis</i> extract (A, C) and baicalein (B, D) against SARS-CoV-2 in Vero cells. The effects of <i>S. baicalensis</i> extract and baicalein in different viral infection periods were also detected (E).</p>   </div> <p>As the synthesis and function of SARS-CoV-2 3CL<sup>pro</sup> take place inside the host cell, its inhibitors should be effective mainly at the post-entry stage. Since the above data were obtained by full-time incubation, we further tested the inhibition activity of baicalein and <i>S. baicalensis</i> extract at the entry or post-entry stage (see <i>Materials and Methods</i> section in Supporting Information for details). Both baicalein and the extract are active at post-entry stage, while the extract also shows noticeable inhibition activity at the viral entry stage. The high activity and multiple action stages of <i>S. baicalensis</i> crude extract in the antiviral assay implies that it may also interact with other viral or host targets in addition to SARS-CoV-2 3CL<sup>pro</sup> inhibition, which can be further explored in the future.</p> </div> <div class="baicaleinbindssars-cov-23clprotoinhibititsactivity" title="sec"><span class="label" tagx="label" title="label">3.4.</span><div class="title" tagx="title" title="title">
Baicalein binds SARS-CoV-2 3CL<sup>pro</sup> to inhibit its activity</div> <p>To confirm that baicalein and the crude extract inhibit viral replication by directly targeting SARS-CoV-2 3CL<sup>pro</sup> in cells, we tested their anti-SARS-CoV-2 3CL<sup>pro</sup> activity under complex cell environment. As the expression of SARS-CoV-2 3CL<sup>pro</sup> is toxic to mammalian cells<a href="#CIT0036"><sup>36</sup></a>, we used the mixture of HEK293T cell lysate and purified SARS-CoV-2 3CL<sup>pro</sup> for the test. Both baicalein and the crude extract showed inhibition activity under this condition (<a href="#F0002" /><a href="https://doi.org/10.1080/14756366.2021.1873977">Figure S2</a>).</p> <p>We performed molecular docking to understand the inhibitory activity of <i>S. baicalensis</i> ingredients. The docking scores are listed in <a href="https://doi.org/10.1080/14756366.2021.1873977">Table S1</a>. In the docking model, baicalein binds well in the substrate binding site of SARS-CoV-2 3CL<sup>pro</sup> with its 6-OH and 7-OH forming hydrogen bond interactions with the carbonyl group of L141 and the backbone amide group of G143, respectively (<a href="#F0003">Figure 3(A)</a>). In addition, the carbonyl group of baicalein is hydrogen bonded with the backbone amide group of E166. The catalytic residues H41 and C145 are well covered by baicalein, accounting for its inhibitory effect. This computational model is in consistent with the recently reported crystal structure of SARS-CoV-2 3CL<sup>pro</sup> complexed with bacailein<a href="#CIT0030"><sup>30</sup></a>. As the 7-OH in baicalin is in close contact with the protein, there may not be enough space for glycosyl modification, explaining the low activity of baicalin. As for wogonin, the absence of 6-OH together with its additional 8-methoxyl group alters the binding orientation and weakens the binding strength (<a href="#F0003">Figure 3(B)</a>). Hydrogen bond is observed between its 5-OH and the backbone carbonyl group of L141, while the interaction with E166 by its 8-methoxy group is weaker than that formed by the carbonyl group in baicalein.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 3.</span></a></div>   <p>The interactions between SARS-CoV-2 3CL<sup>pro</sup> and <i>S. baicalensis</i> ingredients baicalein (A) and wogonin (B) in the docking models. The overall structure and key residues of SARS-CoV-2 3CL<sup>pro</sup> are shown as grey cartoon and green sticks, respectively. <i>S. baicalensis</i> ingredients are displayed as yellow sticks.</p>   </div> </div> <div class="searchingforbaicaleinanaloguesthatinhibitsars-cov-23clpro" title="sec"><span class="label" tagx="label" title="label">3.5.</span><div class="title" tagx="title" title="title">
Searching for baicalein analogues that inhibit SARS-CoV-2 3CL<sup>pro</sup></div> <p>Based on the docking analysis, we searched for baicalein analogues from available flavonoid suppliers and selected eight flavonoids and two glycosides for experimental testing (<a href="#t0002">Table 2</a>). The docking scores are given in <a href="https://doi.org/10.1080/14756366.2021.1873977">Table S1</a>. Four flavonoid compounds were found to be potent SARS-CoV-2 3CL<sup>pro</sup> inhibitors. Among them, scutellarein is mainly distributed in genus <i>Scutellaria</i> and Erigerontis herba (Dengzhanxixin or Dengzhanhua in Chinese) in its glucuronide form, scutellarin. Scutellarin has long been used in cardiovascular disease treatment for its ability to improve cerebral blood supply<a href="#CIT0037"><sup>37</sup></a>. As shown in <a href="#F0004">Figure 4</a>, scutellarein inhibits SARS-CoV-2 3CL<sup>pro</sup> with an IC<sub>50</sub> value of 5.8Â ÂµM, while scutellarin showed mild inhibitory activity at 50â€‰ÂµM concentration. The other three flavonoid compounds, dihydromyricetin, quercetagetin, and myricetin derived from <i>Ampelopsis japonica</i> (Bailian in Chinese), <i>Eriocaulon buergerianum</i> (Gujingcao in Chinese), and <i>Polygoni avicularis</i> (Bianxu in Chinese), respectively, inhibit SARS-CoV-2 3CL<sup>pro</sup> with IC<sub>50</sub> values of 1.20, 1.24, and 2.86Â ÂµM. Interestingly, scutellarein and myricetin were reported to inhibit the SARS-CoV, indicating their potential as multi-target anti-SARS-CoV-2 agents<a href="#CIT0038"><sup>38</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 4.</span></a></div>   <p>The SARS-CoV-2 3CL<sup>pro</sup> inhibition activity of (A) scutellarein, (B) dihydromyricetin, (C) quercetagetin, and (D) myricetin.</p>   </div> <div class="table-wrap_UNKNOWN" id="t0002" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 2.</span> <p>The anti-SARS-CoV-2 3CL<sup>pro</sup> activity of baicalein analogue flavonoids.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th align="left">Compound</th> <th align="center">Chemical structure</th> <th align="center">IC<sub>50</sub> (Î¼M)</th> <th align="center">% Inhibition at 50â€‰Î¼M</th> </tr> </thead> <tbody valign="top"> <tr> <td align="left">Scutellarein</td> <td align="center"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center">5.80â€‰Â±â€‰0.22</td> <td align="center">â€"</td> </tr> <tr> <td align="left">Dihydromyricetin</td> <td align="center"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center">1.20â€‰Â±â€‰0.09</td> <td align="center">â€"</td> </tr> <tr> <td align="left">Quercetagetin</td> <td align="center"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center">1.24â€‰Â±â€‰0.14</td> <td align="center">â€"</td> </tr> <tr> <td align="left">Myricetin</td> <td align="center"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center">2.86â€‰Â±â€‰0.23</td> <td align="center">â€"</td> </tr> <tr> <td align="left">Scutellarin</td> <td align="center"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center">â€"</td> <td align="center">28.9â€‰Â±â€‰1.6</td> </tr> <tr> <td align="left">5,6-Dihydroxyflavone</td> <td align="center"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center">â€"</td> <td align="center">26.6â€‰Â±â€‰0.4</td> </tr> <tr> <td align="left">6,7-Dihydroxyflavone</td> <td align="center"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center">â€"</td> <td align="center">56.7â€‰Â±â€‰2.0</td> </tr> <tr> <td align="left">Chrysin</td> <td align="center"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center">â€"</td> <td align="center">2.6â€‰Â±â€‰1.1</td> </tr> <tr> <td align="left">Myricetin</td> <td align="center"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center">â€"</td> <td align="center">30.8â€‰Â±â€‰4.6</td> </tr> <tr> <td align="left">Herbacetin</td> <td align="center"><span class="inline-graphic" title="inline-graphic" /></td> <td align="center">â€"</td> <td align="center">59.1â€‰Â±â€‰1.9</td> </tr> </tbody> </table> </div> <p>We further showed that <i>S. baicalensis</i> extract, baicalein, and the four active baicalein analogue compounds also inhibit the activity of SARS-CoV 3CL<sup>pro</sup><i>inÂ vitro</i> (<a href="https://doi.org/10.1080/14756366.2021.1873977">Figure S3</a>), demonstrating their potential as broad spectrum anti-CoV agents. For future development and <i>inÂ vivo</i> studies, the bioavailability of these compounds needs to be considered. Although the bioavailability of baicalein is low in oral administration, its concentration can be increased at lung tissue through intratracheal administration<a href="#CIT0030"><sup>30</sup></a>. We suggest that these compounds can be further optimised or used to search for other TCM herbs containing these compounds or substructures to develop effective treatments for COVID-19 and other coronavirus infectious diseases.</p> </div> </div> <div class="supplementary-material" title="supplementary-material"> <div class="title" tagx="title" title="title">
Supplementary Material</div> <div class="local-data" title="local-data">  <div class="title" tagx="title" title="title">
Supplemental Material</div>  <div class="media" title="media"><a href="IENZ_A_1873977_SM3004.pdf">LINK</a> <p>Click here for additional data file.</p>  </div> </div> </div> </div> <div class="back" title="back"> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Disclosure statement</div> <p>No potential conflict of interest was reported by the author(s).</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="CIT0001" /><span class="label" tagx="label" title="label">1</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zumla</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chan</span><span class="given-names" tagx="given-names" title="given-names">JF</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Azhar</span><span class="given-names" tagx="given-names" title="given-names">EI</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Coronaviruses â€" drug discovery and therapeutic options</span>. <span class="source" tagx="source" title="source">Nat Rev Drug Discov</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">15</span>:<span class="fpage" tagx="fpage" title="fpage">327</span>â€"<span class="lpage" tagx="lpage" title="lpage">47</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26868298">26868298</a></span></span></li> <li tag="ref"><a name="CIT0002" /><span class="label" tagx="label" title="label">2</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Adedeji</span><span class="given-names" tagx="given-names" title="given-names">AO</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sarafianos</span><span class="given-names" tagx="given-names" title="given-names">SG.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antiviral drugs specific for coronaviruses in preclinical development</span>. <span class="source" tagx="source" title="source">Curr Opin Virol</span><span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">45</span>â€"<span class="lpage" tagx="lpage" title="lpage">53</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24997250">24997250</a></span></span></li> <li tag="ref"><a name="CIT0003" /><span class="label" tagx="label" title="label">3</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">A novel coronavirus from patients with pneumonia in China, 2019</span>. <span class="source" tagx="source" title="source">N Engl J Med</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">382</span>:<span class="fpage" tagx="fpage" title="fpage">727</span>â€"<span class="lpage" tagx="lpage" title="lpage">33</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31978945">31978945</a></span></span></li> <li tag="ref"><a name="CIT0004" /><span class="label" tagx="label" title="label">4</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">A new coronavirus associated with human respiratory disease in China</span>. <span class="source" tagx="source" title="source">Nature</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">579</span>:<span class="fpage" tagx="fpage" title="fpage">265</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32015508">32015508</a></span></span></li> <li tag="ref"><a name="CIT0005" /><span class="label" tagx="label" title="label">5</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</span>. <span class="source" tagx="source" title="source">Lancet</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">395</span>:<span class="fpage" tagx="fpage" title="fpage">565</span>â€"<span class="lpage" tagx="lpage" title="lpage">74</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32007145">32007145</a></span></span></li> <li tag="ref"><a name="CIT0006" /><span class="label" tagx="label" title="label">6</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">On the origin and continuing evolution of SARS-CoV-2</span>. <span class="source" tagx="source" title="source">Natl Sci Rev</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">1012</span>â€"<span class="lpage" tagx="lpage" title="lpage">23</span>.</span></li> <li tag="ref"><a name="CIT0007" /><span class="label" tagx="label" title="label">7</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Structure, function, and evolution of coronavirus spike proteins</span>. <span class="source" tagx="source" title="source">Annu Rev Virol</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">3</span>:<span class="fpage" tagx="fpage" title="fpage">237</span>â€"<span class="lpage" tagx="lpage" title="lpage">61</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27578435">27578435</a></span></span></li> <li tag="ref"><a name="CIT0008" /><span class="label" tagx="label" title="label">8</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lan</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ge</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor</span>. <span class="source" tagx="source" title="source">Nature</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">581</span>:<span class="fpage" tagx="fpage" title="fpage">215</span>â€"<span class="lpage" tagx="lpage" title="lpage">20</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32225176">32225176</a></span></span></li> <li tag="ref"><a name="CIT0009" /><span class="label" tagx="label" title="label">9</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pillaiyar</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Manickam</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Namasivayam</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">59</span>:<span class="fpage" tagx="fpage" title="fpage">6595</span>â€"<span class="lpage" tagx="lpage" title="lpage">628</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26878082">26878082</a></span></span></li> <li tag="ref"><a name="CIT0010" /><span class="label" tagx="label" title="label">10</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2006</span>;<span class="volume" tagx="volume" title="volume">49</span>:<span class="fpage" tagx="fpage" title="fpage">3440</span>â€"<span class="lpage" tagx="lpage" title="lpage">3</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16759084">16759084</a></span></span></li> <li tag="ref"><a name="CIT0011" /><span class="label" tagx="label" title="label">11</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xie</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xue</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Design of wide-spectrum inhibitors targeting coronavirus main proteases</span>. <span class="source" tagx="source" title="source">PLoS Biol</span><span class="year" tagx="year" title="year">2005</span>;<span class="volume" tagx="volume" title="volume">3</span>:<span class="fpage" tagx="fpage" title="fpage">e324</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16128623">16128623</a></span></span></li> <li tag="ref"><a name="CIT0012" /><span class="label" tagx="label" title="label">12</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">CY</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Jan</span><span class="given-names" tagx="given-names" title="given-names">JT</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">SH</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Small molecules targeting severe acute respiratory syndrome human coronavirus</span>. <span class="source" tagx="source" title="source">Proc Natl Acad Sci U S A</span><span class="year" tagx="year" title="year">2004</span>;<span class="volume" tagx="volume" title="volume">101</span>:<span class="fpage" tagx="fpage" title="fpage">10012</span>â€"<span class="lpage" tagx="lpage" title="lpage">7</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15226499">15226499</a></span></span></li> <li tag="ref"><a name="CIT0013" /><span class="label" tagx="label" title="label">13</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Jin</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors</span> . <span class="source" tagx="source" title="source">Nature</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">582</span>:<span class="fpage" tagx="fpage" title="fpage">289</span>â€"<span class="lpage" tagx="lpage" title="lpage">93</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32272481">32272481</a></span></span></li> <li tag="ref"><a name="CIT0014" /><span class="label" tagx="label" title="label">14</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved Î±-ketoamide inhibitors</span>. <span class="source" tagx="source" title="source">Science</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">368</span>:<span class="fpage" tagx="fpage" title="fpage">409</span>â€"<span class="lpage" tagx="lpage" title="lpage">12</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32198291">32198291</a></span></span></li> <li tag="ref"><a name="CIT0015" /><span class="label" tagx="label" title="label">15</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Dai</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">XM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease</span>. <span class="source" tagx="source" title="source">Science</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">368</span>:<span class="fpage" tagx="fpage" title="fpage">1331</span>â€"<span class="lpage" tagx="lpage" title="lpage">5</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32321856">32321856</a></span></span></li> <li tag="ref"><a name="CIT0016" /><span class="label" tagx="label" title="label">16</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">De Clercq</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Therapeutic options for the 2019 novel coronavirus (2019-nCoV)</span>. <span class="source" tagx="source" title="source">Nat Rev Drug Discov</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">19</span>:<span class="fpage" tagx="fpage" title="fpage">149</span>â€"<span class="lpage" tagx="lpage" title="lpage">50</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32127666">32127666</a></span></span></li> <li tag="ref"><a name="CIT0017" /><span class="label" tagx="label" title="label">17</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Qi</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical trial analysis of 2019-nCoV therapy registered in China</span>. <span class="source" tagx="source" title="source">J Med Virol</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">92</span>:<span class="fpage" tagx="fpage" title="fpage">540</span>â€"<span class="lpage" tagx="lpage" title="lpage">5</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32108352">32108352</a></span></span></li> <li tag="ref"><a name="CIT0018" /><span class="label" tagx="label" title="label">18</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Luo</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">QL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shang</span><span class="given-names" tagx="given-names" title="given-names">YX</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs</span>. <span class="source" tagx="source" title="source">Chin J Integr Med</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">26</span>:<span class="fpage" tagx="fpage" title="fpage">243</span>â€"<span class="lpage" tagx="lpage" title="lpage">50</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32065348">32065348</a></span></span></li> <li tag="ref"><a name="CIT0019" /><span class="label" tagx="label" title="label">19</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="collab'">collab: Chinese Pharmacopoeia Commission</span></span><span class="source" tagx="source" title="source">Pharmacopoeia of the People's Republic of China</span>. <span class="edition" tagx="edition" title="edition">2015 ed.</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Beijing (China)</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">China Medical Science and Technology Press</span>; <span class="year" tagx="year" title="year">2015</span>.</span></li> <li tag="ref"><a name="CIT0020" /><span class="label" tagx="label" title="label">20</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="collab'">collab: European Directorate for the Quality of Medicines of European Council.</span></span><span class="source" tagx="source" title="source">European Pharmacopoeia</span>. <span class="edition" tagx="edition" title="edition">10th ed.</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Strasbourg (France)</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">European Directorate for the Quality of Medicines of European Council</span>; <span class="year" tagx="year" title="year">2019</span>.</span></li> <li tag="ref"><a name="CIT0021" /><span class="label" tagx="label" title="label">21</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">ZL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kuang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">A comprehensive review on phytochemistry, pharmacology, and flavonoid biosynthesis of <i>Scutellaria baicalensis</i></span>. <span class="source" tagx="source" title="source">Pharm Biol</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">56</span>:<span class="fpage" tagx="fpage" title="fpage">465</span>â€"<span class="lpage" tagx="lpage" title="lpage">84</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31070530">31070530</a></span></span></li> <li tag="ref"><a name="CIT0022" /><span class="label" tagx="label" title="label">22</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Oo</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Teoh</span><span class="given-names" tagx="given-names" title="given-names">BT</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sam</span><span class="given-names" tagx="given-names" title="given-names">SS</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Baicalein and baicalin as Zika virus inhibitors</span>. <span class="source" tagx="source" title="source">Arch Virol</span><span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">164</span>:<span class="fpage" tagx="fpage" title="fpage">585</span>â€"<span class="lpage" tagx="lpage" title="lpage">93</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30392049">30392049</a></span></span></li> <li tag="ref"><a name="CIT0023" /><span class="label" tagx="label" title="label">23</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ji</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Anti-H1N1 virus, cytotoxic and Nrf2 activation activities of chemical constituents from <i>Scutellaria baicalensis</i></span>. <span class="source" tagx="source" title="source">J Ethnopharmacol</span><span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">176</span>:<span class="fpage" tagx="fpage" title="fpage">475</span>â€"<span class="lpage" tagx="lpage" title="lpage">84</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26578185">26578185</a></span></span></li> <li tag="ref"><a name="CIT0024" /><span class="label" tagx="label" title="label">24</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Inhibition of HIV replication by baicalin and <i>S. baicalensis</i> extracts in H9 cell culture</span>. <span class="source" tagx="source" title="source">Chin Med Sci J</span><span class="year" tagx="year" title="year">1991</span>;<span class="volume" tagx="volume" title="volume">6</span>:<span class="fpage" tagx="fpage" title="fpage">230</span>â€"<span class="lpage" tagx="lpage" title="lpage">2</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/1813061">1813061</a></span></span></li> <li tag="ref"><a name="CIT0025" /><span class="label" tagx="label" title="label">25</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zandi</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lim</span><span class="given-names" tagx="given-names" title="given-names">TH</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rahim</span><span class="given-names" tagx="given-names" title="given-names">NA</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Extract of <i>Scutellaria baicalensis</i> inhibits dengue virus replication</span>. <span class="source" tagx="source" title="source">BMC Complement Altern Med</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">13</span>:<span class="fpage" tagx="fpage" title="fpage">91</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23627436">23627436</a></span></span></li> <li tag="ref"><a name="CIT0026" /><span class="label" tagx="label" title="label">26</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Efficacy of <i>Scutellaria baicalensis</i> for the treatment of hand, foot, and mouth disease associated with encephalitis in patients infected with EV71: a multicenter, retrospective analysis</span>. <span class="source" tagx="source" title="source">Biomed Res Int</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">2016</span>:<span class="fpage" tagx="fpage" title="fpage">5697571</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27840828">27840828</a></span></span></li> <li tag="ref"><a name="CIT0027" /><span class="label" tagx="label" title="label">27</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Qiao</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">A targeted strategy to analyze untargeted mass spectral data: rapid chemical profiling of <i>Scutellaria baicalensis</i> using ultra-high performance liquid chromatography coupled with hybrid quadrupole orbitrap mass spectrometry and key ion filtering</span>. <span class="source" tagx="source" title="source">J Chromatogr A</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">1441</span>:<span class="fpage" tagx="fpage" title="fpage">83</span>â€"<span class="lpage" tagx="lpage" title="lpage">95</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26952367">26952367</a></span></span></li> <li tag="ref"><a name="CIT0028" /><span class="label" tagx="label" title="label">28</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Jo</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shin</span><span class="given-names" tagx="given-names" title="given-names">DH</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Inhibition of SARS-CoV 3CL protease by flavonoids</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">35</span>:<span class="fpage" tagx="fpage" title="fpage">145</span>â€"<span class="lpage" tagx="lpage" title="lpage">51</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31724441">31724441</a></span></span></li> <li tag="ref"><a name="CIT0029" /><span class="label" tagx="label" title="label">29</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Jo</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors</span>. <span class="source" tagx="source" title="source">Chem Biol Drug Des</span><span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">94</span>:<span class="fpage" tagx="fpage" title="fpage">2023</span>â€"<span class="lpage" tagx="lpage" title="lpage">30</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31436895">31436895</a></span></span></li> <li tag="ref"><a name="CIT0030" /><span class="label" tagx="label" title="label">30</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Su</span><span class="given-names" tagx="given-names" title="given-names">HX</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yao</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">WF</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Anti-SARS-CoV-2 activities inÂ vitro of Shuanghuanglian preparations and bioactive ingredients</span>. <span class="source" tagx="source" title="source">Acta Pharmacol Sin</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">41</span>:<span class="fpage" tagx="fpage" title="fpage">1167</span>â€"<span class="lpage" tagx="lpage" title="lpage">77</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32737471">32737471</a></span></span></li> <li tag="ref"><a name="CIT0031" /><span class="label" tagx="label" title="label">31</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wei</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Feng</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase</span>. <span class="source" tagx="source" title="source">J Biol Chem</span><span class="year" tagx="year" title="year">2004</span>;<span class="volume" tagx="volume" title="volume">279</span>:<span class="fpage" tagx="fpage" title="fpage">1637</span>â€"<span class="lpage" tagx="lpage" title="lpage">42</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14561748">14561748</a></span></span></li> <li tag="ref"><a name="CIT0032" /><span class="label" tagx="label" title="label">32</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Qi</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Teng</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase</span>. <span class="source" tagx="source" title="source">J Biol Chem</span><span class="year" tagx="year" title="year">2010</span>;<span class="volume" tagx="volume" title="volume">285</span>:<span class="fpage" tagx="fpage" title="fpage">28134</span>â€"<span class="lpage" tagx="lpage" title="lpage">40</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20489209">20489209</a></span></span></li> <li tag="ref"><a name="CIT0033" /><span class="label" tagx="label" title="label">33</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China</span>. <span class="source" tagx="source" title="source">JAMA</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">323</span>:<span class="fpage" tagx="fpage" title="fpage">1061</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32031570">32031570</a></span></span></li> <li tag="ref"><a name="CIT0034" /><span class="label" tagx="label" title="label">34</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wei</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism</span>. <span class="source" tagx="source" title="source">Biochemistry</span><span class="year" tagx="year" title="year">2004</span>;<span class="volume" tagx="volume" title="volume">43</span>:<span class="fpage" tagx="fpage" title="fpage">4568</span>â€"<span class="lpage" tagx="lpage" title="lpage">74</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15078103">15078103</a></span></span></li> <li tag="ref"><a name="CIT0035" /><span class="label" tagx="label" title="label">35</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li-Weber</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin</span>. <span class="source" tagx="source" title="source">Cancer Treat Rev</span><span class="year" tagx="year" title="year">2009</span>;<span class="volume" tagx="volume" title="volume">35</span>:<span class="fpage" tagx="fpage" title="fpage">57</span>â€"<span class="lpage" tagx="lpage" title="lpage">68</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19004559">19004559</a></span></span></li> <li tag="ref"><a name="CIT0036" /><span class="label" tagx="label" title="label">36</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Resnick</span><span class="given-names" tagx="given-names" title="given-names">SJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Iketani</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hong</span><span class="given-names" tagx="given-names" title="given-names">SJ</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> A simplified cell-based assay to identify coronavirus 3CL protease inhibitors. bioRxiv. <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="CIT0037" /><span class="label" tagx="label" title="label">37</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Therapeutic effects of breviscapine in cardiovascular diseases: a review</span>. <span class="source" tagx="source" title="source">Front Pharmacol</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">289</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28588491">28588491</a></span></span></li> <li tag="ref"><a name="CIT0038" /><span class="label" tagx="label" title="label">38</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">MS</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">22</span>:<span class="fpage" tagx="fpage" title="fpage">4049</span>â€"<span class="lpage" tagx="lpage" title="lpage">54</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22578462">22578462</a></span></span></li> </ul> </div> </div>  </body></html>